在帕金森病中用于运动康复的技术设备中整合游戏化:范围审查
Pere Bosch-Barceló1,2,3, Oriol Martínez-Navarro1,2,4, Maria Masbernat-Almenara1,2,4
1Department of Nursing and Physiotherapy, Universitat de Lleida, C/ Montserrat Roig, nº2, Lleida, 25198, Spain, 34 973702430.
JMIR serious games
|July 4, 2025
概括
具有游戏化的技术设备增强了帕金森病的康复. 然而,尽管它们被广泛使用,但它们的应用往往缺乏明确的理由和理论依据.
科学领域:
- 神经学 神经学
- 康复技术 康复技术 康复技术
- 人与计算机的交互
背景情况:
- 帕金森病 (PD) 是一个日益增长的全球神经系统疾病.
- 物理治疗和运动是PD的关键干预措施.
- 整合技术和游戏化可以改善PD康复中的坚持和运动症状.
研究的目的:
- 识别和分类使用游戏化用于PD运动康复的技术设备.
- 分析使用这些技术和游戏化元素背后的逻辑.
主要方法:
- 根据乔安娜·布里格斯研究所和PRISMA-ScR指南进行范围审查.
- 系统地搜索主要的健康科学数据库.
- 在符合条件的研究中,对游戏化要素和理由的内容分析.
主要成果:
- 包括81项研究,确定了453个游戏化元素.
- 进展/反 (98%),点 (86%) 和水平/进展 (81%) 是最常见的.
- 商业视频游戏 (41%) 和计算机系统 (40%) 主导着交付平台,但故意使用游戏化很少.
结论:
- 游戏化技术在PD运动康复中被广泛使用.
- 在理解和证明游戏化机制方面存在很大的差距.
- 目前的方法大大支持商业游戏和性能指标,而不是理论基础.
更多相关视频
04:49Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
Published on: September 6, 2024
888
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
3.9K
相关概念视频
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
